Table 3.
Baseline characteristics of final 1354 subjects
| Baseline characteristic | N (%) | Median | IQR (1st, 3rd quartile) |
|---|---|---|---|
| Age (years) | 31.6 | 24.1, 41.9 | |
| Sex | |||
| Male | 959 (70.8%) | ||
| Female | 395 (29.2%) | ||
| Ethnicity | |||
| African | 924 (68.2%) | ||
| Asian | 430 (31.8%) | ||
| Diabetes | |||
| Yes | 69 (5%) | ||
| No | 1285 (95%) | ||
| HIV | |||
| Yes | 104 (7.7%) | ||
| No | 1250 (92.3%) | ||
| Albumin (g/L) | 34 | 30, 38 | |
| Body mass index (kg/m2) | 18.5 | 16.9, 20.3 | |
| Grade 3+ tuberculosis symptoms | |||
| 0 | 1271 (93.9%) | ||
| 1 | 60 (4.4%) | ||
| 2 | 16 (1.2%) | ||
| 3 | 7 (0.5%) | ||
| 4 | 1 (0.07%) | ||
| Time to positivity (hours) | 117 | 89, 153 | |
| Cavity | |||
| Yes | 1049 (77.5%) | ||
| No | 305 (22.5%) | ||
| Average area affected (%) | 18.13 | 11.25, 27.5 | |